Table 4 Turnaround time for RAS testing results by country and testing practices
Turnaround time (working days) | ||||
|---|---|---|---|---|
Variable (n) | Criterion | ≤5 (%) | 6–10 (%) | >10 (%) |
n = 3,191 | 1,511 (47.4) | 1,389 (43.5) | 291 (9.1) | |
Countrya n = 3,171 | Austria (n = 201) | 152 (75.6) | 49 (24.4) | 0 (0.0) |
Belgium (n = 240) | 70 (29.2) | 93 (38.8) | 77 (32.1) | |
Czech Republic (n = 90) | 4 (4.4) | 65 (72.2) | 21 (23.3) | |
Denmark (n = 120) | 77 (64.2) | 39 (32.5) | 4 (3.3) | |
France (n = 238) | 60 (25.2) | 111 (46.6) | 67 (28.2) | |
Italy (n = 276) | 109 (39.5) | 149 (54.0) | 18 (6.5) | |
Netherlands (n = 457) | 259 (56.7) | 194 (42.5) | 4 (0.9) | |
Norway (n = 74) | 29 (39.2) | 27 (36.5) | 18 (24.3) | |
Poland (n = 80) | 43 (53.8) | 32 (40.0) | 5 (6.3) | |
Spain (n = 192) | 55 (28.7) | 134 (69.8) | 3 (1.6) | |
Sweden (n = 82) | 6 (7.3) | 72 (87.8) | 4 (4.9) | |
Switzerland (n = 415) | 354 (85.3) | 56 (13.5) | 5 (1.2) | |
Turkey (n = 90) | 0 (0.0) | 66 (73.3) | 24 (26.7) | |
Number of patients tested per year (n = 3,191) | >80 | 828 (40.0) | 1,022 (49.3) | 222 (10.7) |
≤80 | 683 (61.0) | 367 (32.8) | 69 (6.2) | |
RAS mutations tested (n = 3,191) | All codons tested | 983 (44.4) | 1,102 (49.8) | 130 (5.9) |
Not all codons tested | 528 (54.1) | 287 (29.4) | 161 (16.5) | |
Same testing method for all codons (n = 3,191) | Yes | 1,345 (50.1) | 1,142 (42.6) | 197 (7.3) |
No | 166 (32.7) | 247 (48.7) | 94 (18.5) | |
Indication for RAS testing (n = 3,161) | “On request from an oncologist” | 1,325 (46.2) | 1,288 (44.9) | 258 (9.0) |
“All CRC patients tested” | 36 (32.1) | 56 (50.0) | 20 (17.9) | |
“Other” | 132 (74.2) | 33 (18.5) | 13 (7.3) | |
Location of testing (n = 3,191) | Own institution | 1,496 (48.8) | 1,343 (43.9) | 224 (7.3) |
Own institution and external | 15 (11.7) | 46 (35.9) | 67 (52.3) | |